Improved survival in homozygous sickle cell disease: lessons from a cohort study.
about
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell diseaseProphylactic antibiotics for preventing pneumococcal infection in children with sickle cell diseaseInformation exploration system for sickle cell disease and repurposing of hydroxyfasudilTime to Invest in Sickle Cell Anemia as a Global Health Priority.Predicted declines in sickle allele frequency in Jamaica using empirical data.Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.Costing model for neonatal screening and diagnosis of haemoglobinopathies.Management of sickle cell disease. Non-addictive analgesics can be as effective as morphine and pethidine.Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.Improved survival of children and adolescents with sickle cell disease.Neonatal screening for sickle cell disease.Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement.Newborn screening for sickle cell disease: technical and legal aspects of a German pilot study with 38,220 participants.One hundred years of sickle cell disease.Routine paediatric sickle cell disease (SCD) outpatient care in a rural Kenyan hospital: utilization and costsProphylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions.Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach.Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, GermanyNT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease.Management of sickle cell disease in primary care.Survival of children with sickle cell disease.The lived experiences of adolescents with sickle cell disease in Kingston, JamaicaBacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified?Longitudinal Analysis of Patient Specific Predictors for Mortality in Sickle Cell Disease.The medical home experience among children with sickle cell disease.Sickle cell disease: acute clinical manifestations in early childhood and molecular characteristics in a group of children in Rio de JaneiroBacteraemia in sickle cell anaemia is associated with low haemoglobin: a report of 890 admissions to a tertiary hospital in TanzaniaAge at diagnosis of sickle cell anaemia in lagos, Nigeria.Sickle cell disease in Africa: burden and research prioritiesSickle cell disease in North Europe.Sickle cell disease in India: A perspectiveNewborn screening for sickle cell disease: A 1988-2003 Quebec experienceThe natural history of sickle cell disease.The changing face of homozygous sickle cell disease: 102 patients over 60 years.Association of care in a medical home and health care utilization among children with sickle cell diseaseOcular manifestations of sickle cell disease.The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease.Improving outcomes in children with sickle cell disease: treatment considerations and strategies.Healthcare utilization and expenditures for low income children with sickle cell disease.
P2860
Q24188084-FB89FB59-F1BF-4B58-AAE4-0E82551DF492Q24200730-B0C86315-5E46-446B-A737-166EB6AC7A42Q28533770-B1F9149B-DAC3-46EE-88F1-9D589552957AQ30376725-73A01A08-C06B-4D23-BD66-09DC6B2FDB08Q33255072-F6416AF2-A436-4B1A-8F7F-A207CBF0EB41Q33315119-7C922C6F-B884-4F6D-924E-DE8F139F398AQ33589306-B8A67A5B-FC69-4F40-A96C-A9A188E7CD58Q33789475-55C33A39-D36D-4208-815E-B23D5FC99C08Q33831797-38FC84C8-68DC-4150-B6C7-7ED5BCECA879Q33839801-FA434429-2B92-40E4-8151-7D4F3B66640AQ33910009-2BE72C5F-D6E7-42F0-8C09-3A6923662A94Q33920754-6CCCAF32-DED4-4C4E-B103-0EF3338A6BD9Q34043349-7D2AD69D-9828-4173-A443-3939504DC03CQ34144286-FF9C9E91-5359-463D-93DF-E783921428B3Q34674639-78239272-02F5-46D6-8118-A10EFC5C7F8BQ34758278-C0D773FB-3424-4D1B-B318-67D9FB02997FQ34844899-95DF7D58-41E2-4CEE-A9BC-EBD61AE636DEQ35076607-CF400A5E-A579-497F-A10B-811CE9BD4949Q35150519-67DE24DB-64D5-4F49-AF26-D9E1E178010BQ35508045-B7BDD14A-F1CA-4F69-985F-6BF82D0611D0Q35611782-A71BFAF1-64FB-4B05-A567-4872B0F78037Q35690101-7B2F592C-7568-43ED-AF2F-DF816B528AD2Q36029928-790420CA-704C-4B75-9538-2DDF3CBFFB1BQ36153927-CB635BCE-5E42-4155-8511-84B1280A05AFQ36169208-3BC03CB5-F6C6-49CB-8346-EB577DD592FFQ36189287-DC64366F-C9D3-4656-82DA-0B2C2A3F569CQ36283833-05864629-5D18-4B13-BFFC-A97F815D5A96Q36554542-455C8C6B-5898-4D00-959E-5FA45A397115Q36555876-08943EEF-11A9-4FEA-B6CB-D1B78924B957Q36715984-CE867061-9EBF-49D7-A85A-016CD83FE5D0Q36762093-A7C4262B-60B7-4795-A65D-112A4BB8AF2BQ36769676-77547903-476F-4574-939B-FC95204E3C53Q36860438-F4F2DC96-C92F-4564-BBA3-F8A92212CE78Q37201472-E65A5AE3-7C23-4E61-A26B-8B5C41699D4EQ37222739-6315FB07-D69D-43CD-ADDE-D2317A8A0CADQ37325960-F9AA0F2A-C98E-4966-B532-4BB9400C8990Q37701543-18999075-207B-4054-A563-0F8E9757F18EQ38176054-5769A939-FE13-4CC9-8EB8-04EFCF3CD96EQ38209472-BD673B98-5374-4811-870F-66E6013DF608Q38454000-7B594CFC-E0F8-44B5-A674-E169E72B42F8
P2860
Improved survival in homozygous sickle cell disease: lessons from a cohort study.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Improved survival in homozygous sickle cell disease: lessons from a cohort study.
@en
Improved survival in homozygous sickle cell disease: lessons from a cohort study.
@nl
type
label
Improved survival in homozygous sickle cell disease: lessons from a cohort study.
@en
Improved survival in homozygous sickle cell disease: lessons from a cohort study.
@nl
prefLabel
Improved survival in homozygous sickle cell disease: lessons from a cohort study.
@en
Improved survival in homozygous sickle cell disease: lessons from a cohort study.
@nl
P2093
P2860
P1433
P1476
Improved survival in homozygous sickle cell disease: lessons from a cohort study.
@en
P2093
P2860
P304
P356
10.1136/BMJ.311.7020.1600
P407
P577
1995-12-01T00:00:00Z